MDR 1.04% 47.5¢ medadvisor limited

Ann: MDR Mar-17 Quarterly Report and 4C, page-2

  1. 5,368 Posts.
    lightbulb Created with Sketch. 1199
    Another Record Quarter for MedAdvisor Highlights

    • Operating cash receipts for the quarter increased by 17% on December 2016 and 472% on pcp to $1.55 million, with total cash receipts totalling $2.04 million which included a $493k R&D tax refund
    • Revenue of $1.27 million recognised during the quarter, an increase of 21% on the December 2016 quarter • Revenue growth driven by increasing user-based revenue, up 41% on December 2016 quarter and accounting for ~50% of revenue base vs 50% in subscription revenue in the quarter
    • Operational performance across key metrics remained strong o Now over 700,000 users on the MedAdvisor platform, an increase of 12% on the prior quarter
    • Completion of OzDocsOnline delivered new services to MedAdvisor’s offering and bought relationships with +100 new clinics and +300 GPs
    • The company is fully funded and closed the quarter with $5.75 million cash at bank to continue to invest in its growth initiatives focused on driving user and revenue growth

    http://www.aspecthuntley.com.au/doc...lc2lnbmFsL2Vycm9ycGFnZXMvcGRmZGVsYXllZC5qc3A=
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.